New Drugs Center for Drug Evaluation / World Health Organization / DIVISION OF CARDIO-RENAL DRUG PRODUCTS Memo / Food and Drug Administration / FDA Briefing Document Cardiovascular and Renal Drugs Advisory Committee / Advisory Committee / CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE / Cardiovascular and Renal Products Office / Review Division / /
Person
Salim Yusuf / /
Position
Director Memorandum of Contents Page Division / Senior Medical Officer / Division / /
FDA Briefing Document Cardiovascular and Renal Drugs Advisory Committee Meeting September 10, 2014 To discuss the potential clinical utility of fixedcombination prescription drugs composed of an antihypertensive drug, as